Pentadecanoic acid-d₃

Cat. No.: HY-W004283S1: FAQs
Data Sheet Handling Instructions

Molarity Calculator

Pentadecanoic acid-d₃ is the deuterium labeled Pentadecanoic acid. Pentadecylic acid is a saturated fatty acid with a 15-carbon backbone.

For research use only. We do not sell to patients.

Pentadecanoic acid-d<sub>3</sub> Chemical Structure

Pentadecanoic acid-d₃ Chemical Structure

CAS No. : 352431-40-4

Size	Price	Stock	Quantity
5 mg	USD 562	Get quote 3 - 4 weeks 4 - 5 weeks 2 - 3 weeks	Estimated Time of Arrival: December 31
10 mg		Get quote
50 mg		Get quote

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Pentadecanoic acid-d₃:

Pentadecanoic acid In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Pentadecanoic acid-d₃ is the deuterium labeled Pentadecanoic acid. Pentadecylic acid is a saturated fatty acid with a 15-carbon backbone.
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Pentadecanoic acid-d₃ Related Antibodies
Molecular Weight	245.42
Formula	C₁₅H₂₇D₃O₂
CAS No.	352431-40-4
Unlabeled CAS	1002-84-2
SMILES	[2H]C([2H])([2H])CCCCCCCCCCCCCC(O)=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (260 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]